Jan   Feb   Mar   Apr   May   Jun   Jul   Aug   Sept   Oct   Nov   Dec

July

Think tank calls for FDA to forgo approval of drugs cleared by European regulator
The Hill
The free-market Pacific Research Institute argues in a new report that American patients would benefit if the Food and Drug Administration didn’t have a monopoly on regulations. Read More... 

NIH chief lobbies for $500M fund to back clinical trials
Fierce Biotech
NIH chief Francis Collins is lobbying Congress to set aside a half-billion dollar fund that will give start-up biotechs up to $15 million to bankroll clinical trials for new drugs that treat neglected diseases. The initiative marks a strategic shift for the NIH, which has played a big role sponsoring the academic research that often winds up in developers' hands. Read More...

June

Developers lobby for new federal R&D incentives for rare diseases
Fierce Biotech
Charged with spurring greater R&D efforts on new drugs for rare diseases, the FDA's newly formed rare disease review group plans to meet today and tomorrow and will hear about a host of new ideas on a richer set of research incentives. Read More...

Which FDA Advisory Committee is the Toughest?
Wall Street Journal
While the recommendations of the FDA’s advisory committees aren’t binding, the agency usually follows their advice. So the track records of those committees, analyzed in a new research note from Concept Capital’s Washington Research Group, are of interest. Read More...

May

Rejected Drugs May Be Disclosed by FDA for First Time
Bloomberg.com
Drug rejections, plant inspections and detailed side-effect reports would be shared with consumers for the first time under a new plan from U.S. regulators. Read More...

Johansson to testify before Congress on lending bills
Baltimore Business Journal
Christian S. Johansson, secretary for the Maryland Department of Business and Economic Development, will testify Tuesday on Capitol Hill in favor of federal legislation that would help small businesses with a proven track record secure loans. Read More...

April

FDA seeks new disclosure from panel members
Bloomberg.com
The U.S. Food and Drug Administration would disclose which companies or institutions create a potential conflict of interest for advisory panel members, under a proposal posted Wednesday on the agency's website. Read More...

Cancer Research by U.S. Disorganized, Underfunded, Study Says
Bloomberg.com
The U.S. government’s cancer research network is “approaching a state of crisis” as waste and inefficiency cause 40 percent of late-stage trials it funds to be abandoned before completion, a report found. Read More...

March

WSJ: FDA mapping new, faster path for cocktail drugs
Fierce Biotech
The FDA has set its sights on a new and faster development pathway for drug cocktails, which could have a big impact on the therapeutic prospects for a slate of major diseases like cancer, AIDS, tuberculosis and hepatitis. And the Wall Street Journal reports that the initiative has helped inspire a major new development collaboration among pharma companies that will soon be announced. Read More...

February

FDA creates partnership to boost regulatory science
Los Angeles Times
The Food and Drug Administration and the National Institutes of Health on Wednesday announced a plan to help the FDA make swifter decisions about the safety and effectiveness of new products and procedures that flow from advanced research. Read More...

NIST Grants Awards for Recovery Act Fellowship Programs
NIST News Release
The U.S. Commerce Department's National Institute of Standards and Technology (NIST) announced today that it is awarding a total of $20 million to the University of Maryland and the University of Colorado to develop and implement NIST measurement science and engineering fellowship programs.  The new fellowship programs were funded under the American Recovery and Reinvestment Act (ARRA) of 2009. Read More...

January

Researchers Find Study of Medical Marijuana Discouraged
NY Times
Despite the Obama administration’s tacit support of more liberal state medical marijuana laws, the federal government still discourages research into the medicinal uses of smoked marijuana. Read More...

Obama at odds with some Dems on key provision in healthcare
The Hill
President Barack Obama is looking to change a key healthcare reform provision passed by both the House and Senate, triggering a dispute with some lawmakers in his own party; governors rush to defense of bipartisan biologics deal. Read More

Study: Biomedical research funding is slowing
FierceBiotech
After a decade of doubling, the rate of increase in biomedical research funding slowed between 2003 and 2007. Adjusting for inflation, the absolute level of funding from the NIH and industry appears to have decreased by 2 percent in 2008, according to a study in the Journal of the American Medical Association. Read More...

NIH Awards Over $5,000,000 for Tβ4 Research in 2009/2010
BusinessWire
REGENERX announced today that National Institutes of Health (NIH) has awarded 12 research grants totaling over $5,000,000 for the study of Tβ4 in 2009/2010. Many of these grants will be going to collaborators.
Read More...

Study: Biomedical research funding is slowing
FierceBiotech
After a decade of doubling, the rate of increase in biomedical research funding slowed between 2003 and 2007. Adjusting for inflation, the absolute level of funding from the NIH and industry appears to have decreased by 2 percent in 2008, according to a study in the Journal of the American Medical Association. Read More...

back to top

February  March  April  May  Jun  July  August  September  October  November  December